Optimal felodipine dose when combined with metoprolol in arterial hypertension: a Swedish multicenter study within primary health care. Swedish General Practitioner Felodipine Study Group
- PMID: 1693732
Optimal felodipine dose when combined with metoprolol in arterial hypertension: a Swedish multicenter study within primary health care. Swedish General Practitioner Felodipine Study Group
Abstract
In a multicenter study comprising 23 Swedish primary health care centers, felodipine extended-release (ER) tablets in doses of 5, 10, and 20 mg were compared double-blind with placebo when given in addition to metoprolol controlled-release (CR) tablets 100 mg. All medication was given once daily in the morning. Altogether, 251 hypertensive patients with a diastolic blood pressure greater than 95 mm Hg after 4 weeks of treatment with placebo in combination with metoprolol CR 100 mg were randomized to four parallel groups. After 4 weeks of treatment, there were significantly greater reductions in blood pressure with all doses of felodipine ER than with placebo, both 2 and 24 h after intake of the tablets. Twelve patients were withdrawn because of adverse reactions. Of these, one patient was taking placebo, one 5 mg of felodipine ER, four 10 mg of felodipine ER, and six patients 20 mg of felodipine ER. When combined with metoprolol, 5 mg of felodipine ER seemed to be less effective than higher doses, but was very well tolerated. Adding 10 mg of felodipine ER to the basal metoprolol appeared to be optimal if both the effect and adverse reactions were taken into consideration.
Similar articles
-
A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).Am J Hypertens. 2006 Apr;19(4):388-95. doi: 10.1016/j.amjhyper.2005.10.007. Am J Hypertens. 2006. PMID: 16580575 Clinical Trial.
-
Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.Blood Press Suppl. 1993;1:22-9. Blood Press Suppl. 1993. PMID: 8173687 Clinical Trial.
-
Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group.Blood Press Suppl. 1993;1:30-6. Blood Press Suppl. 1993. PMID: 8173688 Clinical Trial.
-
Improving the therapeutic balance between efficacy and tolerability in antihypertensive drugs--the rationale and benefits of combining felodipine and metoprolol.J Hum Hypertens. 1995 Jul;9 Suppl 2:S37-42. J Hum Hypertens. 1995. PMID: 7562898 Review.
-
Comparison of felodipine extended release and conventional tablets in essential hypertension using ambulatory blood pressure monitoring.J Hypertens. 1989 Aug;7(8):645-51. doi: 10.1097/00004872-198908000-00008. J Hypertens. 1989. PMID: 2681410 Review.
Cited by
-
Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.Drugs. 1992 Aug;44(2):251-77. doi: 10.2165/00003495-199244020-00008. Drugs. 1992. PMID: 1382018 Review.
-
Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension.Drugs. 2000 Jan;59(1):141-57. doi: 10.2165/00003495-200059010-00011. Drugs. 2000. PMID: 10718104 Review.
-
Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.Drugs. 1992 Mar;43(3):382-414. doi: 10.2165/00003495-199243030-00006. Drugs. 1992. PMID: 1374320 Review.
-
Grapefruit juice and drugs. How significant is the interaction?Clin Pharmacokinet. 1994 Feb;26(2):91-8. doi: 10.2165/00003088-199426020-00002. Clin Pharmacokinet. 1994. PMID: 8162660 Review. No abstract available.
-
Evaluation of three methods of symptom reporting in a clinical trial of felodipine.Eur J Clin Pharmacol. 1991;41(3):187-96. doi: 10.1007/BF00315428. Eur J Clin Pharmacol. 1991. PMID: 1748134 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical